SCHEMBL30799739

SCHEMBL30799739

CC(C)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(N)=O

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NPY5R Q15761 3/20 0.38
▸ NPY1R P25929 2/20 0.38
▸ NPY4R P50391 2/20 0.38
▸ NOD1 Q9Y239 1/20 0.37
▸ MMP2 P08253 2/20 0.37
▸ MMP9 P14780 2/20 0.37
▸ MMP8 P22894 2/20 0.37
▸ ERAP2 Q6P179 1/20 0.37
▸ ERAP1 Q9NZ08 1/20 0.37
▸ LNPEP Q9UIQ6 1/20 0.37
▸ DPP4 P27487 1/20 0.37
▸ PTPN1 P18031 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.36
▸ LAP3 P28838 3/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ CTSB P07858 1/20 0.35
▸ CTSK P43235 1/20 0.35
▸ BIRC2 Q13490 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30799781 0.97 DPP4 (0.39) NPY5RNPY1RNPY4RNOD1MMP2
SCHEMBL29531361 0.87 ALDH1A1 (0.51) ALDH1A1LAP3
SCHEMBL29629477 0.87 ALDH1A1 (0.51) ALDH1A1LAP3
SCHEMBL30913906 0.87 ALDH1A1 (0.43) MMP2ALDH1A1LAP3
SCHEMBL1711472 0.87 ALDH1A1 (0.51) ALDH1A1LAP3
SCHEMBL1711477 0.87 ALDH1A1 (0.51) ALDH1A1LAP3
SCHEMBL7324204 0.85 SLC7A5 (0.41) NPY5RNPY1RNPY4RMMP2MMP9
SCHEMBL7324200 0.85 SLC7A5 (0.41) NPY5RNPY1RNPY4RMMP2MMP9
SCHEMBL7442182 0.85 SLC7A5 (0.41) NPY5RNPY1RNPY4RMMP2MMP9
SCHEMBL9510271 0.84 ALDH1A1 (0.41) NOD1ALDH1A1LAP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240116985-A1 STAPLED PEPTIDES AND METHODS THEREOF PARABILIS MEDICINES, INC. 2024-04-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240116985-A1 STAPLED PEPTIDES AND METHODS THEREOF CTNNB1, APC, CTNNA1 NPY5R 333/4885NPY1R 249/4885NPY4R 444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback